Home Cart Sign in  
Chemical Structure| 61613-20-5 Chemical Structure| 61613-20-5

Structure of 61613-20-5

Chemical Structure| 61613-20-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Ahmed A. Elbatrawy ; Taiwo A. Ademoye ; Heba Alnakhala ; Arati Tripathi ; Ashique Zami ; Raluca Ostafe , et al.

Abstract: Tau and aggregates are the main histopathological hallmarks present in Alzheimer’s disease (AD), Parkinson’s disease (PD), and other neurodegenerative disorders. Intraneuronal hyperphosphorylated tau accumulation is significantly connected to the degree of cognitive impairment in AD patients. In particular, the longest 2N4R tau isoform has a propensity to rapidly form oligomers and mature fibrils. On the other hand, misfolding of (α-syn) is the characteristic feature in PD and dementia with Lewy bodies (DLB). There is a strong crosstalk between the two prone-to-aggregation proteins as they coprecipitated in some brains of AD, PD, and DLB patients. Simultaneous targeting of both proteinaceous oligomers and aggregates is still challenging. Here, we rationally designed and synthesized benzothiazole- and indole-based compounds using the structural hybridization strategy between the benzothiazole N744 cyanine dye and the diphenyl pyrazole that showed anti-aggregation activity towards 2N4R tau and α-syn, respectively. The anti-aggregation effect of the prepared compounds was monitored using the thioflavin-T (ThT) fluorescence assay, while transmission electron microscopy (TEM) was employed to detect fibrils upon the completion of a time-course study with the assay. Moreover, the photo-induced crosslinking of unmodified protein (PICUP) assay was used to determine the formation of oligomers. Specifically, compounds 46 and 48 demonstrated the highest anti-aggregation activity by decreasing the fluorescence to 4.0 and 14.8%, respectively, against α-syn. Although no noticeable effect on 2N4R tau oligomers, 46 showed promising anti-oligomer activity against α-syn. Both compounds induced a significantly high anti-aggregation effect against the two protein fibrils as visualized by TEM. Moreover, compound 48 remarkably inhibited α-syn inclusion and cell confluence using M17D cells. Collectively, compounds 46 and 48 could serve as a basic structure for further optimization to develop clinically active AD and PD disease-modifying agents.

Keywords: Alzheimer’s disease ; Parkinson’s disease ; Alpha-synuclein ; Tau isoforms ; Anti-oligomer agents

Purchased from AmBeed: ;

Alternative Products

Product Details of [ 61613-20-5 ]

CAS No. :61613-20-5
Formula : C13H12INO2S
M.W : 373.21
SMILES Code : O=S(C1=CC=C(C)C=C1)(NC2=CC=CC=C2I)=O
InChI Key :TZKVYDXSGFMXDH-UHFFFAOYSA-N
Pubchem ID :1375894

Safety of [ 61613-20-5 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 61613-20-5 ]

Aryls

Chemical Structure| 158268-30-5

A947337 [158268-30-5]

N-(4-Iodophenyl)-4-methylbenzenesulfonamide

Similarity: 0.93

Chemical Structure| 54189-90-1

A354011 [54189-90-1]

N-(2-Iodophenyl)benzenesulfonamide

Similarity: 0.93

Chemical Structure| 56751-80-5

A116517 [56751-80-5]

N-(2-Iodophenyl)-N,4-dimethylbenzenesulfonamide

Similarity: 0.88

Chemical Structure| 314054-07-4

A429604 [314054-07-4]

N-(4-Iodophenyl)-2,4,6-trimethylbenzenesulfonamide

Similarity: 0.88

Chemical Structure| 6965-75-9

A386679 [6965-75-9]

4-Amino-N-(4-iodophenyl)benzenesulfonamide

Similarity: 0.87

Amines

Chemical Structure| 158268-30-5

A947337 [158268-30-5]

N-(4-Iodophenyl)-4-methylbenzenesulfonamide

Similarity: 0.93

Chemical Structure| 54189-90-1

A354011 [54189-90-1]

N-(2-Iodophenyl)benzenesulfonamide

Similarity: 0.93

Chemical Structure| 56751-80-5

A116517 [56751-80-5]

N-(2-Iodophenyl)-N,4-dimethylbenzenesulfonamide

Similarity: 0.88

Chemical Structure| 314054-07-4

A429604 [314054-07-4]

N-(4-Iodophenyl)-2,4,6-trimethylbenzenesulfonamide

Similarity: 0.88

Chemical Structure| 6965-75-9

A386679 [6965-75-9]

4-Amino-N-(4-iodophenyl)benzenesulfonamide

Similarity: 0.87

Sulfamides

Chemical Structure| 158268-30-5

A947337 [158268-30-5]

N-(4-Iodophenyl)-4-methylbenzenesulfonamide

Similarity: 0.93

Chemical Structure| 54189-90-1

A354011 [54189-90-1]

N-(2-Iodophenyl)benzenesulfonamide

Similarity: 0.93

Chemical Structure| 56751-80-5

A116517 [56751-80-5]

N-(2-Iodophenyl)-N,4-dimethylbenzenesulfonamide

Similarity: 0.88

Chemical Structure| 314054-07-4

A429604 [314054-07-4]

N-(4-Iodophenyl)-2,4,6-trimethylbenzenesulfonamide

Similarity: 0.88

Chemical Structure| 6965-75-9

A386679 [6965-75-9]

4-Amino-N-(4-iodophenyl)benzenesulfonamide

Similarity: 0.87

Iodides

Chemical Structure| 158268-30-5

A947337 [158268-30-5]

N-(4-Iodophenyl)-4-methylbenzenesulfonamide

Similarity: 0.93

Chemical Structure| 54189-90-1

A354011 [54189-90-1]

N-(2-Iodophenyl)benzenesulfonamide

Similarity: 0.93

Chemical Structure| 56751-80-5

A116517 [56751-80-5]

N-(2-Iodophenyl)-N,4-dimethylbenzenesulfonamide

Similarity: 0.88

Chemical Structure| 314054-07-4

A429604 [314054-07-4]

N-(4-Iodophenyl)-2,4,6-trimethylbenzenesulfonamide

Similarity: 0.88

Chemical Structure| 6965-75-9

A386679 [6965-75-9]

4-Amino-N-(4-iodophenyl)benzenesulfonamide

Similarity: 0.87